Ashland signs definitive agreement to sell nutraceuticals business to Turnspire Capital Partners
Ashland's nutraceuticals business supplies a broad portfolio of active ingredients and formulation aids to nutritional product companies
Ashland's nutraceuticals business supplies a broad portfolio of active ingredients and formulation aids to nutritional product companies
NexGard Spectra is a soft, flavourful monthly chew that kills fleas before they can lay eggs
Aims to become a leading global partner for botanical extracts and natural actives in the beauty and personal care market
Wacker Biotech is a CDMO for the GMP-compliant production of active ingredients for the pharmaceutical industry
New institute brings together Evonik’s most advanced biotech platform and a global network of evaluation labs
Microdosing has emerged as a key trend in the pharmaceutical and nutritional markets
Oteseconazole Capsules were found to be safe and more effective than fluconazole
Luforbec® 100/6 pMDI aims to provide comprehensive support to patients and healthcare professionals
This acquisition will significantly strengthen Croda’s Beauty Actives portfolio and increases its exposure to targeted prestige segments
Total investments could reach €70 million, of which approximately 15% in R&D and 85% in capex, that would be deployed from 2026
Subscribe To Our Newsletter & Stay Updated